These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7846263)

  • 1. Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group B.
    Ahles TA; Silberfarb PM; Rundle AC; Holland JC; Kornblith AB; Canellos GP; Green MR; Perry MC
    Psychother Psychosom; 1994; 62(3-4):193-9. PubMed ID: 7846263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B.
    Ahles TA; Silberfarb PM; Herndon J; Maurer LH; Kornblith AB; Aisner J; Perry MC; Eaton WL; Zacharski LL; Green MR; Holland JC
    J Clin Oncol; 1998 May; 16(5):1954-60. PubMed ID: 9586915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines.
    Hügli A; Moro D; Mermillod B; Bolla M; Alberto P; Bonnefoi H; Miralbell R
    J Clin Oncol; 2000 Apr; 18(8):1662-7. PubMed ID: 10764426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer.
    Garces YI; Okuno SH; Schild SE; Mandrekar SJ; Bot BM; Martens JM; Wender DB; Soori GS; Moore DF; Kozelsky TF; Jett JR
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):995-1001. PubMed ID: 17336213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovations in multimodality therapy for lung cancer. Combined modality management of limited small-cell lung cancer.
    Turrisi AT
    Chest; 1993 Jan; 103(1 Suppl):56S-59S. PubMed ID: 8380135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
    Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
    J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.
    Brooks BJ; Seifter EJ; Walsh TE; Lichter AS; Bunn PA; Zabell A; Johnston-Early A; Edison M; Makuch RW; Cohen MH
    J Clin Oncol; 1986 Feb; 4(2):200-9. PubMed ID: 3003259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
    Schild SE; Bonner JA; Shanahan TG; Brooks BJ; Marks RS; Geyer SM; Hillman SL; Farr GH; Tazelaar HD; Krook JE; Geoffroy FJ; Salim M; Arusell RM; Mailliard JA; Schaefer PL; Jett JR
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):943-51. PubMed ID: 15234027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.
    Work E; Nielsen OS; Bentzen SM; Fode K; Palshof T
    J Clin Oncol; 1997 Sep; 15(9):3030-7. PubMed ID: 9294465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083.
    Perry MC; Herndon JE; Eaton WL; Green MR
    J Clin Oncol; 1998 Jul; 16(7):2466-7. PubMed ID: 9667265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS; McCarley DL; Zlotecki RA
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.
    Johnson DH; Turrisi AT; Chang AY; Blum R; Bonomi P; Ettinger D; Wagner H
    J Clin Oncol; 1993 May; 11(5):879-84. PubMed ID: 8387577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer and quality of life.
    Thongprasert S
    Aust N Z J Med; 1998 Jun; 28(3):397-9. PubMed ID: 9673757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
    Komaki R; Shin DM; Glisson BS; Fossella FV; Murphy WK; Garden AS; Oswald MJ; Hong WK; Roth JA; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):807-11. PubMed ID: 7860392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of radiotherapy on tumor and mediastinum as a combined treatment with chemotherapy in patients with limited small cell lung carcinoma].
    Szczepek B; Roszkowski K; Dańczak-Ginalska Z; Starzyńska T; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1993; 61(9-10):445-51. PubMed ID: 8111319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
    Grosshans DR; Meyers CA; Allen PK; Davenport SD; Komaki R
    Cancer; 2008 Feb; 112(3):589-95. PubMed ID: 18098269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.